Pembrolizumab plus allogeneic NK cells in advanced non–small cell lung cancer patients

Journal: Journal of Clinical Investigation

Published: 2020-02-06

DOI: 10.1172/jci132712

Affiliations: 6

Authors: 7

Go to article
Institutions Share
Guangdong Provincial Key Laboratory of Proteomics, SMU, China 0.29
Fuda Cancer Hospital, JNU, China 0.29
Medical Research Center, SYSU, China 0.14
Nanfang Hospital, China 0.14
Department of Pathophysiology, SMU, China 0.14